Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASAP
3751
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
| $869K | ﹤0.01% |
49,093
+1,731
| +4% | +$46.4K |
|
|
LMPX
3752
DELISTED
LMP Automotive Holdings, Inc. Common Stock
LMPX
| $868K | ﹤0.01% |
56,445
+3,178
| +6% | +$51.8K |
|
|
GMBL
3753
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
| $867K | ﹤0.01% |
3
| – | – |
|
|
OTIC
3754
DELISTED
Otonomy, Inc.
OTIC
| $867K | ﹤0.01% |
451,702
+24,308
| +6% | +$41.2K |
|
|
APTX
3755
DELISTED
Aptinyx Inc. Common Stock
APTX
| $866K | ﹤0.01% |
370,128
-4
| -0% | -$10 |
|
|
NBSE
3756
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $865K | ﹤0.01% |
11,991
+298
| +3% | +$22.8K |
|
|
AGPU
3757
Axe Compute Inc
AGPU
$96M
| $864K | ﹤0.01% |
2,166
+784
| +57% | +$263K |
|
3758
Pro-Dex
PDEX
$217M
| $861K | ﹤0.01% |
33,229
-219
| -0.7% | -$6.22K |
|
3759
Paysign
PAYS
$735M
| $858K | ﹤0.01% |
318,072
+28,753
| +10% | +$77K |
|
3760
LiqTech
LIQT
$19.7M
| $857K | ﹤0.01% |
19,557
+245
| +1% | +$11.5K |
|
|
CNVY
3761
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $857K | ﹤0.01% |
+102,134
| New | +$909K |
|
3762
Banco Santander
SAN
$211B
| $855K | ﹤0.01% |
236,250
-12,554
| -5% | -$46.4K |
|
|
CDTX
3763
DELISTED
Cidara Therapeutics
CDTX
| $854K | ﹤0.01% |
19,081
+873
| +5% | +$33.2K |
|
3764
Valhi
VHI
$466M
| $854K | ﹤0.01% |
36,606
-1,900
| -5% | -$44.7K |
|
|
SIOX
3765
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $854K | ﹤0.01% |
393,804
-14,283
| -3% | -$31.1K |
|
3766
Regis Corp
RGS
$70.1M
| $853K | ﹤0.01% |
12,256
-6,928
| -36% | -$910K |
|
3767
Minerva Neurosciences
NERV
$187M
| $850K | ﹤0.01% |
61,102
+5,380
| +10% | +$80.9K |
|
|
SBT
3768
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $850K | ﹤0.01% |
164,845
-16
| -0% | -$80 |
|
3769
Richardson Electronics
RELL
$300M
| $848K | ﹤0.01% |
87,600
+1,317
| +2% | +$10.9K |
|
|
BIOL
3770
DELISTED
Biolase, Inc.
BIOL
| $846K | ﹤0.01% |
529
+45
| +9% | +$73.5K |
|
|
PCTI
3771
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $845K | ﹤0.01% |
135,962
+363
| +0.3% | +$2.37K |
|
3772
Riley Exploration Permian
REPX
$786M
| $844K | ﹤0.01% |
35,949
+10,638
| +42% | +$226K |
|
3773
SCYNEXIS
SCYX
$50.9M
| $844K | ﹤0.01% |
19,928
-592
| -3% | -$31K |
|
3774
Oak Valley Bancorp
OVLY
$288M
| $841K | ﹤0.01% |
47,345
+7,963
| +20% | +$141K |
|
3775
Cocrystal Pharma
COCP
$15.2M
| $840K | ﹤0.01% |
66,717
+20,189
| +43% | +$267K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.